JP2024536868A5 - - Google Patents
Info
- Publication number
- JP2024536868A5 JP2024536868A5 JP2024518874A JP2024518874A JP2024536868A5 JP 2024536868 A5 JP2024536868 A5 JP 2024536868A5 JP 2024518874 A JP2024518874 A JP 2024518874A JP 2024518874 A JP2024518874 A JP 2024518874A JP 2024536868 A5 JP2024536868 A5 JP 2024536868A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- cycloalkyl
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248561P | 2021-09-27 | 2021-09-27 | |
| US63/248,561 | 2021-09-27 | ||
| US202163273395P | 2021-10-29 | 2021-10-29 | |
| US63/273,395 | 2021-10-29 | ||
| PCT/US2022/076999 WO2023049885A1 (en) | 2021-09-27 | 2022-09-26 | Benzimidazole and azabenzimidazole il-17 inhibitor compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536868A JP2024536868A (ja) | 2024-10-08 |
| JP2024536868A5 true JP2024536868A5 (enExample) | 2025-09-30 |
Family
ID=83995644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518874A Pending JP2024536868A (ja) | 2021-09-27 | 2022-09-26 | ベンズイミダゾール及びアザベンズイミダゾールｉｌ－１７阻害剤化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250122181A1 (enExample) |
| EP (1) | EP4408837A1 (enExample) |
| JP (1) | JP2024536868A (enExample) |
| CA (1) | CA3233622A1 (enExample) |
| WO (1) | WO2023049885A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| AU2024213283A1 (en) * | 2023-01-30 | 2025-08-14 | Dice Alpha, Inc. | Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof |
| CN117567323A (zh) * | 2023-10-30 | 2024-02-20 | 湖北泰盛化工有限公司 | 一种(s)-4-氯-2-((甲氧基羰基)氨基)丁酸乙酯的制备方法 |
| WO2025104230A1 (en) * | 2023-11-17 | 2025-05-22 | Sanofi | Benzoxazoles as modulators of il-17a |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010011959A1 (en) | 2008-07-25 | 2010-01-28 | Gilead Sciences, Inc. | Antiviral compounds |
| CN111601799B (zh) * | 2018-01-15 | 2023-06-09 | Ucb生物制药有限责任公司 | 作为Il-17调节剂的稠合咪唑衍生物 |
| TWI752400B (zh) * | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| WO2021170627A1 (en) * | 2020-02-25 | 2021-09-02 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| EP3943495A1 (en) * | 2020-07-24 | 2022-01-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| CN113999234B (zh) * | 2020-07-28 | 2023-03-07 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
-
2022
- 2022-09-26 CA CA3233622A patent/CA3233622A1/en active Pending
- 2022-09-26 WO PCT/US2022/076999 patent/WO2023049885A1/en not_active Ceased
- 2022-09-26 US US18/693,202 patent/US20250122181A1/en active Pending
- 2022-09-26 JP JP2024518874A patent/JP2024536868A/ja active Pending
- 2022-09-26 EP EP22794009.5A patent/EP4408837A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524018A5 (enExample) | ||
| JP2024536869A5 (enExample) | ||
| JP2024536863A5 (enExample) | ||
| JP2024536862A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| IL311751A (en) | IL-17 imidazopyridazine inhibitory compounds | |
| EP2044023B1 (en) | Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors | |
| JP2024167182A5 (enExample) | ||
| JP6111308B2 (ja) | インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート | |
| JP2024546950A5 (enExample) | ||
| JP2024546951A5 (enExample) | ||
| JP2012521994A5 (enExample) | ||
| JP2009534406A5 (enExample) | ||
| JP2013533884A5 (enExample) | ||
| JP2015501820A5 (enExample) | ||
| JP2020502047A5 (enExample) | ||
| JP2017534591A5 (enExample) | ||
| JP2025509697A5 (enExample) | ||
| JP2023512664A5 (enExample) | ||
| JP2021528405A5 (enExample) | ||
| JP2022529518A5 (enExample) | ||
| CA2290136A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| JP2024001236A5 (enExample) | ||
| HK1048302A1 (zh) | 前列腺素衍生物 | |
| JP2022526675A5 (enExample) |